APOG exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet stability. While the current price of $38.29 is slightly above the Graham Number ($31.86), it trades at a significant discount to its growth-based intrinsic value of $55.17 and a very attractive forward P/E of 10.73. Despite stagnant revenue growth and a bearish technical trend, the company's consistent track record of earnings beats and conservative debt-to-equity ratio (0.56) provide a strong margin of safety. The combination of deep value and high deterministic health makes this a compelling long-term play.